Clearwater intends to use proceeds from the Term Loan, together with the issuance of equity, to fund the previously announced acquisition of Enfusion, Inc. (NYSE: ENFN ) ("Enfusion") for a total transaction price of approximately $1.5 billion. About Clearwater Analytics Clearwater Analytics (NYSE: CWAN ), a global, industry-leading SaaS solution, automates the entire investment lifecycle. With a single instance, multi-tenant architecture, Clearwater offers award-winning investment portfolio planning, performance reporting, data aggregation, reconciliation, accounting, compliance, risk, and order management. Each day, leading insurers, asset managers, corporations, and governments use Clearwater's trusted data to drive efficient, scalable investing on more than $7.3 trillion in assets spanning traditional and alternative asset types. Additional information about Clearwater can be found at clearwateranalytics.com.